MedPath

Comparative confirmatory study of K-877

Phase 3
Conditions
Dyslipidemia
Registration Number
JPRN-jRCT2080222569
Lead Sponsor
Kowa Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
225
Inclusion Criteria

(1)Patients who have been placed on dietary or exercise therapy for 12 weeks or longer prior to the initiation of treatment period
(2)men or postmenopausal women
(3)20 years or older at the time of informed consent
etc

Exclusion Criteria

(1)Type 1 diabetes mellitus or poorly controlled Type 2 diabetes mellitus
-HbA1c(NGSP): >= 8.0%(at the screening test)
(2)Poorly controlled hypertension
-SBP: >=160 and/or DBP: >=100 mmHg (at the screening test)
(3)Poorly controlled thyroid disorder
etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath